China Blood Products Market Increases Steadily, Driven By Increased Price And Government's Stricter Supervision
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The sale of blood products in China reached $3.966 billion in 2008 with an annual growth rate 12.23 percent, according to consulting company Draco Healthcare. The growth will continue in the future, driven by increasing demand, limited supply and higher prices